Michael P Stansky insider trades: TriSalus Life Sciences (TLSI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | TLSI | ↑ Buy | 243,900 | $4.10 | $1000K | Direct | Feb 23, 2026 (0d) |
| Feb 23, 2026 | TLSI | ↑ Buy | 117,198 | $4.10 | $481K | By LLC | Feb 23, 2026 (0d) |
| Feb 20, 2008 | MAKO | ↑ Buy | 189,827 | $10.00 | $1.9M | By The Raptor Global Portfolio Ltd. | Feb 22, 2008 (2d) |
| Feb 20, 2008 | MAKO | ↑ Buy | 58,496 | $10.00 | $585K | By The Tudor BVI Global Portfolio L.P. | Feb 22, 2008 (2d) |
| Feb 20, 2008 | MAKO | ↑ Buy | 1,677 | $10.00 | $17K | By The Altar Rock Fund L.P. | Feb 22, 2008 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TLSI insiders
Open-market trades in the last 12 months
About Michael P Stansky's insider trades
Michael P Stansky is a director at TriSalus Life Sciences (TLSI). Since Feb 20, 2008, Michael has reported 5 open-market purchases worth $4.0M and no sales on SEC Form 4. In the last 12 months: 2 buys ($1.5M).
Their filings also include grants and awards (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TLSI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.